Related Experiment Videos
[Early detection of atherosclerosis].
M Depairon1, D Hayoz, R Darioli
1Service d'angiologie, Département de médecine, CHUV, Lausanne. michele.depairon@chuv.ch
Revue Medicale Suisse
|March 4, 2006
Summary
Subclinical disease measurements, like high-resolution ultrasound, can improve cardiovascular risk prediction beyond traditional factors. This method detects early atherosclerosis in asymptomatic patients, aiding disease management.
Area of Science:
- Cardiology
- Vascular Medicine
- Medical Imaging
Background:
- Cardiovascular risk assessment traditionally relies on established risk factors.
- Significant variability in atherosclerosis exists despite similar risk factor exposure.
- Existing methods may not fully capture individual atherosclerosis progression.
Purpose of the Study:
- To evaluate subclinical disease measurements for enhanced cardiovascular risk prediction.
- To compare high-resolution ultrasound with the ankle-brachial index for early atherosclerosis detection.
- To explore novel approaches for cardiovascular disease risk stratification and therapy monitoring.
Main Methods:
- Utilized high-resolution B-mode ultrasound to assess carotid and femoral arterial walls.
- Included asymptomatic patients to evaluate early signs of atherosclerosis.
- Compared ultrasound findings with traditional cardiovascular risk factor assessments.
Main Results:
- High-resolution ultrasound demonstrated promise in detecting early atherosclerosis in asymptomatic individuals.
- Ultrasound identified subclinical disease on both carotid and femoral arterial walls.
- Substantial variation in atherosclerosis was observed across different levels of risk factor exposure.
Conclusions:
- Subclinical disease measurement, particularly via high-resolution ultrasound, can improve cardiovascular risk prediction.
- High-resolution ultrasound is a valuable tool for detecting early atherosclerosis in asymptomatic patients.
- This imaging technique offers a new approach for cardiovascular disease risk management and therapy monitoring.